Jüri Ratas Antiarrhythmic drug Pharmaceutical compound Aprindine is a Class 1b antiarrhythmic agent.[1] References ^ "WHOCC - ATC/DDD Index". WHO Collaborating Centre for Drug Statistics Methodology. Retrieved 2018-03-01. Antiarrhythmic agents (C01B)Channel blockersclass I(Na+ channel blockers)class Ia (Phase 0→ and Phase 3→) Ajmaline Disopyramide Hydroquinidine Lorajmine Prajmaline Procainamide# Quinidine# Sparteine class Ib (Phase 3←) IV Lidocaine# enteral Aprindine Mexiletine Tocainide class Ic (Phase 0→) Encainide‡ Ethacizine Flecainide Indecainide‡ Lorcainide Moracizine‡ Propafenone class III(Phase 3→, K+ channel blockers) Amiodarone Bretylium Bunaftine Celivarone† Dofetilide Dronedarone E-4031† Ibutilide Nifekalant Sotalol Tedisamil Vernakalant class IV(Phase 4→, Ca2+ channel blockers) Diltiazem Verapamil# Receptor agonistsand antagonistsclass II(Phase 4→, β blockers) Nadolol Pindolol Propranolol cardioselective Acebutolol Atenolol Esmolol Landiolol Metoprolol A1 agonist Adenosine Benzodiazepines Barbiturates M2 muscarinic antagonist: Atropine Disopyramide Quinidinemuscarinic agonist: Digoxin α receptors Amiodarone Bretylium Quinidine Verapamil Ion transportersNa+/ K+-ATPase Digitoxin Digoxin Ouabain #WHO-EM ‡Withdrawn from market Clinical trials: †Phase III §Never to phase III No tags for this post. Navigeerimine Mihhail VellerKaja Kallas
You must be logged in to post a comment.